Living donor versus deceased donor liver transplantation for hepatocellular carcinoma: A meta-analysis
Liver Transplantation, 06/12/2012
Liang W et al. – The findings demonstrate that Living donor liver transplantation (LDLT) represents an acceptable option that does not compromise patient survival or increase hepatocellular carcinoma (HCC) recurrence when compared to deceased donor liver transplantation (DDLT) for HCC patients, especially those within Milan criteria.



